Emboline, Inc. Secures $20 Million in Growth Capital from Trinity Capital Inc. to Support Commercialization of the Emboliner® Embolic Protection System to Minimize Stroke Risk From TAVR

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

Emboline-TAVR

More Like This

Emboline Announces First U.S. Commercial Use of the Emboliner® Embolic Protection System

Emboline, Inc. Completes Enrollment in U.S. Pivotal IDE Trial of the Emboliner® Embolic Protection Catheter Designed to Protect Patients from Embolic Injury During Transcatheter Aortic Valve Replacement

PR Newswire associated0

Emboline Receives U.S. FDA 510(k) Clearance for Emboliner® Embolic Protection System

Emboline, Inc. Files Patent Infringement Suit Against AorticLab s.r.l. Regarding Embolic Protection Medical Device

PR Newswire associated0

Emboline Announces Positive Pivotal PROTECT H2H Trial Results for Emboliner® Presented as a Late-Breaking Clinical Trial at ACC 2026

PR Newswire associated0

Emboline Prevails in German Utility Model Infringement Action Against AorticLab

Protembis Announces Completion of € 30 Million Series B Financing Round and the Addition of Keith D Dawkins MD to the Board of Directors

The ProtEmbo Cerebral Embolic Protection system in the Aortic Arch (Graphic: Business Wire)

German Medtech Protembis Gets €20 Million EIB Backing for Technology to Protect Brain During Heart Treatment